Deutsche Bank
CRBP icon

Deutsche Bank’s Corbus Pharmaceuticals CRBP Stock Holding History

Deutsche Bank’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,045
Closed -$37.4K – 3628
2025
Q1 		$37.4K Sell
7,045
-1,161
-14% -$10.2K ﹤0.01% 3419
2024
Q4 		$96.8K Buy
8,206
+2,616
+47% +$43.9K ﹤0.01% 3291
2024
Q3 		$115K Buy
5,590
+1,416
+34% +$72.5K ﹤0.01% 3169
2024
Q2 		$189K Buy
+4,174
New +$176K ﹤0.01% 2834
2021
Q3 		– Sell
-1,800
Closed -$98K – 4434
2021
Q2 		$98K Sell
1,800
-457
-20% -$25.4K ﹤0.01% 4153
2021
Q1 		$134K Buy
2,257
+412
+22% +$27.1K ﹤0.01% 3826
2020
Q4 		$70K Buy
1,845
+501
+37% +$18.7K ﹤0.01% 4014
2020
Q3 		$72K Buy
1,344
+232
+21% +$42K ﹤0.01% 3696
2020
Q2 		$280K Buy
1,112
+335
+43% +$67.7K ﹤0.01% 2949
2020
Q1 		$122K Buy
777
+62
+9% +$10.5K ﹤0.01% 3169
2019
Q4 		$117K Buy
715
+159
+29% +$23.5K ﹤0.01% 3511
2019
Q3 		$81K Sell
556
-89
-14% -$15.5K ﹤0.01% 3669
2019
Q2 		$132K Sell
645
-1,526
-70% -$327K ﹤0.01% 4060
2019
Q1 		$451K Buy
2,171
+181
+9% +$39.9K ﹤0.01% 3517
2018
Q4 		$348K Sell
1,990
-2,995
-60% -$598K ﹤0.01% 3556
2018
Q3 		$1.13M Sell
4,985
-3,390
-40% -$548K ﹤0.01% 3238
2018
Q2 		$1.27M Buy
8,375
+5,994
+252% +$1.09M ﹤0.01% 3265
2018
Q1 		$434K Sell
2,381
-1,447
-38% -$325K ﹤0.01% 3789
2017
Q4 		$814K Buy
3,828
+1,326
+53% +$284K ﹤0.01% 3338
2017
Q3 		$535K Sell
2,502
-2,543
-50% -$498K ﹤0.01% 3390
2017
Q2 		$952K Buy
5,045
+1,708
+51% +$335K ﹤0.01% 3063
2017
Q1 		$825K Buy
3,337
+4
+0.1% +$982 ﹤0.01% 2781
2016
Q4 		$845K Buy
3,333
+2,333
+233% +$535K ﹤0.01% 2823
2016
Q3 		$203K Buy
+1,000
New +$124K ﹤0.01% 3643

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Deutsche Bank's CRBP Position: Q2 2025 in Review

Deutsche Bank sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 7,045 shares — an estimated $37.4K sold.

Deutsche Bank first reported a position in CRBP in Q3 2016 and held it in 24 quarters. The position peaked at $1.27M in Q2 2018. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • Deutsche Bank reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 7,045 Corbus Pharmaceuticals shares in Q2 2025, an estimated $37.4K.
  • Deutsche Bank first reported a position in Corbus Pharmaceuticals in Q3 2016 and held it in 24 quarters.
  • Deutsche Bank's Corbus Pharmaceuticals position peaked at $1.27M in Q2 2018.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.